| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
Heart valve (Diseases)Heart valve (Artificial)| 1 | 2002 | Valvar heart disease and prosthetic heart valves. | 
| + | - | nl | BMJ 325(7374):1228-31 (2002) |
| 2 | 1982 | Long-term complications of valve replacement. | 
| + | - | nl | Br Med J (Clin Res Ed) 284(6321):995-7 (1982) |
| 3 | 2002 | The medical management of valvar heart disease. | 
| + | - | nl | Heart 87(4):395-400 (2002) |
| 4 | 2001 | Valve disease: Surgery of valve disease: late results and late complications. | 
| + | - | nl | Heart 86(6):715-21 (2001) |
| 5 | 1992 | The first step to understanding valve failure: an overview of pathology. | 
| + | - | nl | Eur J Cardiothorac Surg 6 Suppl 1(-):S50-3 (1992) |
| 6 | 2008 | Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). | 
| + | - | nl | Chest 133(6 Suppl):593S-629S (2008) |
| 7 | 1986 | Combined valvular and coronary surgery. | 
| + | - | nl | Chest 90(3):312-4 (1986) |
| 8 | 2008 | Percutaneous and minimally invasive valve procedures: a scientific statement from the American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Functional Genomics and Translational Biology Interdisciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group. | 
| + | - | nl | Circulation 117(13):1750-67 (2008) |
| 9 | 2007 | Prospects for percutaneous valve therapies. | 
| + | - | nl | Circulation 116(24):2866-77 (2007) |
| 10 | 2006 | ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. | 
| + | - | nl | Circulation 114(5):e84-231 (2006) |
| 11 | 2004 | Percutaneous approaches to valvular disease. | 
| + | - | nl | Circulation 109(13):1572-9 (2004) |
| 12 | 2004 | Novel approaches to cardiac valve repair: from structure to function: Part II. | 
| + | - | nl | Circulation 109(9):1064-72 (2004) |
| 13 | 2004 | Novel approaches to cardiac valve repair: from structure to function: Part I. | 
| + | - | nl | Circulation 109(8):942-50 (2004) |
| 14 | 1998 | Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). | 
| + | - | nl | Circulation 98(18):1949-84 (1998) |
| 15 | 2007 | Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. | 
| + | - | nl | Eur Heart J 28(2):230-68 (2007) |
| 16 | 2003 | A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. | 
| + | - | nl | Eur Heart J 24(13):1231-43 (2003) |
| 17 | 2007 | Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations. | 
| + | - | nl | Heart 93(1):137-42 (2007) |
| 18 | 2006 | Percutaneous valve repair and replacement techniques. | 
| + | - | nl | Heart 92(10):1369-72 (2006) |
| 19 | 2004 | Management and follow up of prosthetic heart valves. | 
| + | - | nl | Heart 90(7):818-24 (2004) |
| 20 | 2002 | Choice of heart valve prosthesis. | 
| + | - | nl | Heart 87(6):583-9 (2002) |
| 21 | 2008 | 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. | 
| + | - | nl | J Am Coll Cardiol 52(13):e1-142 (2008) |
| 22 | 2008 | ACC/AHA 2008 Guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. | 
| + | - | nl | J Am Coll Cardiol 52(8):676-85 (2008) |
| 23 | 2008 | The year in valvular heart disease. | 
| + | - | nl | J Am Coll Cardiol 51(7):760-70 (2008) |
| 24 | 2007 | The year in valvular heart disease. | 
| + | - | nl | J Am Coll Cardiol 49(3):361-74 (2007) |
| 25 | 2006 | ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. | 
| + | - | nl | J Am Coll Cardiol 48(3):e1-148 (2006) |
| 26 | 2005 | The clinical development of percutaneous heart valve technology: a position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI) Endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA). | 
| + | - | nl | J Am Coll Cardiol 45(9):1554-60 (2005) |
| 27 | 2005 | The year in valvular heart disease. | 
| + | - | nl | J Am Coll Cardiol 45(1):111-22 (2005) |
| 28 | 1998 | ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). | 
| + | - | nl | J Am Coll Cardiol 32(5):1486-588 (1998) |
| 29 | 1997 | Valve excrescences: harmless and common or strokes-in-waiting? | 
| + | - | nl | J Am Coll Cardiol 30(5):1315-6 (1997) Armstrong WF |
| 30 | 2004 | Understanding valvular heart disease in patients with systemic autoimmune diseases. | 
| + | - | nl | Cleve Clin J Med 71(11):881-5 (2004) |
| 31 | 2010 | Valvular heart disease: diagnosis and management. | 
| + | - | nl | Mayo Clin Proc 85(5):483-500 (2010) |
| 32 | 2008 | 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. | 
| + | - | nl | Circulation 118(15):e523-661 (2008) |
| 33 | 2011 | Innovations in therapies for heart valve disease. | 
| + | - | nl | Circ J 75(5):1028-41 (2011) |